Literature DB >> 9739955

First "antisense" drug will treat CMV retinitis.

C Marwick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9739955

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  41 in total

1.  Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides.

Authors:  P Lorenz; T Misteli; B F Baker; C F Bennett; D L Spector
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.

Authors:  P Trang; M Lee; E Nepomuceno; J Kim; H Zhu; F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 3.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  [Do antisense oligonucleotides improve viral immunopathology?].

Authors:  S Wasmuth; D Bauer; K P Steuhl; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059

Review 5.  Oligonucleotide treatment of ras-induced tumors in nude mice.

Authors:  E Wickstrom
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

Review 6.  Therapeutic regulation of gene expression in the inner ear using RNA interference.

Authors:  Yukihide Maeda; Abraham M Sheffield; Richard J H Smith
Journal:  Adv Otorhinolaryngol       Date:  2009-06-02

Review 7.  Therapeutic use of microRNAs in myocardial diseases.

Authors:  Michael V G Latronico; Gianlugi Condorelli
Journal:  Curr Heart Fail Rep       Date:  2011-09

Review 8.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

9.  Therapy and Prevention of Cytomegalovirus Retinitis.

Authors:  Asok Kurup; Francesca J. Torriani
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.725

10.  Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers.

Authors:  Richard M Kinney; Claire Y-H Huang; Becky C Rose; Andrew D Kroeker; Theo W Dreher; Patrick L Iversen; David A Stein
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.